New protein therapy tested for rare brain disease
NCT ID NCT07476352
Summary
This study is testing a new protein therapy called ALT001 in people with multiple system atrophy (MSA), a rare and serious brain disorder. The main goal is to check if the treatment is safe and well-tolerated, while also looking for early signs that it might help slow the disease or improve symptoms. Sixty participants will receive three cycles of treatment over several months, and their health will be closely monitored.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE SYSTEM ATROPHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Beijing Tiantan Hospital
Beijing, Beijing Municipality, 100070, China
Conditions
Explore the condition pages connected to this study.